{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:46:11Z","timestamp":1794570371332,"version":"4.9.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH R01 DK101119"],"award-info":[{"award-number":["NIH R01 DK101119"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["L30 DK126220"],"award-info":[{"award-number":["L30 DK126220"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001359","name":"Ann and Bill Swindells Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Vitamin D downregulates the in vitro expression of the gut-tropic integrin \u03b14\u03b27 on immune cells. The clinical relevance of this finding in patients with inflammatory bowel disease [IBD] is unclear. We tested the hypothesis that vitamin D is associated with \u03b14\u03b27 immunophenotypes and risk of vedolizumab [anti-\u03b14\u03b27] failure in IBD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed single-cell immunophenotyping of peripheral and intestinal immune cells using mass cytometry [CyTOF] in vedolizumab-na\u00efve patients with IBD [N = 48]. We analysed whole-genome mucosal gene expression [GSE73661] from GEMINI I and GEMINI long-term safety [LTS] to determine the association between vitamin D receptor [VDR] and integrin alpha-4 [ITGA4] and beta-7 [ITGB7] genes. We estimated the odds of vedolizumab failure with low pre-treatment vitamin D in a combined retrospective and prospective IBD cohort [N = 252] with logistic regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Immunophenotyping revealed that higher 25[OH]D was associated with decreased \u03b14\u03b27+ peripheral blood mononuclear cells [R = -0.400, p &amp;lt;0.01] and \u03b14\u03b27+ intestinal leukocytes [R = -0.538, p = 0.03]. Serum 25[OH]D was inversely associated with \u03b14\u03b27+ peripheral B cells and natural killer [NK] cells and \u03b14\u03b27+ intestinal B cells, NK cells, monocytes, and macrophages. Mucosal expression of VDR was inversely associated with ITGA4 and ITGB7 expression. In multivariate analysis, 25[OH]D &amp;lt;25 ng\/mL was associated with increased vedolizumab primary non-response during induction (odds ratio [OR] 26.10, 95% confidence interval [CI] 14.30\u201348.90, p &amp;lt;0.001) and failure at 1-year follow-up [OR 6.10, 95% CI 3.06\u201312.17, p &amp;lt;0.001].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Low serum 25[OH]D is associated with \u03b14\u03b27+ immunophenotypes and predicts future vedolizumab failure in patients with IBD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Podcast<\/jats:title>\n                  <jats:p>This article has an associated podcast which can be accessed at https:\/\/academic.oup.com\/ecco-jcc\/pages\/podcast<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjab114","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T03:14:33Z","timestamp":1624590873000},"page":"1980-1990","source":"Crossref","is-referenced-by-count":29,"title":["Vitamin D Is Associated with \u03b14\u03b27+ Immunophenotypes and Predicts Vedolizumab Therapy Failure in Patients with Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6037-2883","authenticated-orcid":false,"given":"John","family":"Gubatan","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Chan Zuckerberg Biohub, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J S","family":"Rubin","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Immunology Program, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5617-9025","authenticated-orcid":false,"given":"Lawrence","family":"Bai","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Immunology Program, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeneneh","family":"Haileselassie","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Levitte","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Balabanis","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshar","family":"Patel","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidhartha R","family":"Sinha","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Habtezion","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA"},{"name":"Immunology Program, Stanford University School of Medicine, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"2021121823065401500_CIT0001","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.10.046","article-title":"Leukocyte trafficking to the small intestine and colon","volume":"150","author":"Habtezion","year":"2016","journal-title":"Gastroenterology"},{"key":"2021121823065401500_CIT0002","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"key":"2021121823065401500_CIT0003","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med"},{"key":"2021121823065401500_CIT0004","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/apt.14550","article-title":"Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease","volume":"47","author":"Barr\u00e9","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2021121823065401500_CIT0005","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/cpt.1712","article-title":"Vedolizumab for inflammatory bowel disease: two-year results of the Initiative on Crohn and Colitis [ICC] Registry, a nationwide prospective observational cohort study: ICC Registry\u2013Vedolizumab","volume":"107","author":"Biemans","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"2021121823065401500_CIT0006","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MOG.0000000000000449","article-title":"Vitamin D in inflammatory bowel disease: more than just a supplement","volume":"34","author":"Gubatan","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"2021121823065401500_CIT0007","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3109\/10799893.2014.975248","article-title":"Association of vitamin D receptor gene polymorphisms with the susceptibility to ulcerative colitis in patients from Southeast China","volume":"35","author":"Xia","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"key":"2021121823065401500_CIT0008","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/gut.47.2.211","article-title":"Vitamin D receptor gene polymorphism: association with Crohn\u2019s disease susceptibility","volume":"47","author":"Simmons","year":"2000","journal-title":"Gut"},{"key":"2021121823065401500_CIT0009","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cgh.2016.05.035","article-title":"Low serum vitamin D during remission increases risk of clinical relapse in patients with ulcerative colitis","volume":"15","author":"Gubatan","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021121823065401500_CIT0010","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/apt.15506","article-title":"Systematic review with meta-analysis: association of vitamin D status with clinical outcomes in adult patients with inflammatory bowel disease","volume":"50","author":"Gubatan","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2021121823065401500_CIT0011","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2017.12.023","article-title":"Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitis","volume":"103","author":"Gubatan","year":"2018","journal-title":"Cytokine"},{"key":"2021121823065401500_CIT0012","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/ibd\/izz330","article-title":"Cathelicidin mediates a protective role of vitamin D in ulcerative colitis and human colonic epithelial cells","volume":"26","author":"Gubatan","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"2021121823065401500_CIT0013","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/apt.13936","article-title":"Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor-\u03b1 medications among patients with inflammatory bowel diseases","volume":"45","author":"Winter","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2021121823065401500_CIT0014","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.it.2011.10.001","article-title":"How vitamin A metabolizing dendritic cells are generated in the gut mucosa","volume":"33","author":"Agace","year":"2012","journal-title":"Trends Immunol"},{"key":"2021121823065401500_CIT0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ni1433","article-title":"DCs metabolize sunlight-induced vitamin D3 to \u2018program\u2019 T cell attraction to the epidermal chemokine CCL27","volume":"8","author":"Sigmundsdottir","year":"2007","journal-title":"Nat Immunol"},{"key":"2021121823065401500_CIT0016","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/cea.12568","article-title":"Vitamins A and D have antagonistic effects on expression of effector cytokines and gut-homing integrin in human innate lymphoid cells","volume":"45","author":"Ruiter","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"2021121823065401500_CIT0017","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fimmu.2017.00764","article-title":"Clinical response to vedolizumab in ulcerative colitis patients is associated with changes in integrin expression profiles","volume":"8","author":"Fuchs","year":"2017","journal-title":"Front Immunol"},{"key":"2021121823065401500_CIT0018","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0701s85","article-title":"Isolation of whole mononuclear cells from peripheral blood and cord blood","author":"Fuss","year":"2009.","journal-title":"Curr Protoc Immunol"},{"key":"2021121823065401500_CIT0019","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/gut.25.1.32","article-title":"Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques","volume":"25","author":"Selby","year":"1984","journal-title":"Gut"},{"key":"2021121823065401500_CIT0020","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41467-019-10387-7","article-title":"Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases","volume":"10","author":"Rubin","year":"2019","journal-title":"Nat Commun"},{"key":"2021121823065401500_CIT0021","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nbt.2594","article-title":"viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia","volume":"31","author":"Amir","year":"2013","journal-title":"Nat Biotechnol"},{"key":"2021121823065401500_CIT0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2016-312293","article-title":"Effect of vedolizumab [anti-\u03b14\u03b27-integrin] therapy on histological healing and mucosal gene expression in patients with UC","volume":"67","author":"Arijs","year":"2018","journal-title":"Gut"},{"key":"2021121823065401500_CIT0023","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.cgh.2020.02.010","article-title":"Development and validation of clinical scoring tool to predict outcomes of treatment with vedolizumab in patients with ulcerative colitis","volume":"18","author":"Dulai","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021121823065401500_CIT0024","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2018.05.039","article-title":"Development and validation of a scoring system to predict outcomes of vedolizumab treatment in patients with Crohn\u2019s disease","volume":"155","author":"Dulai","year":"2018","journal-title":"Gastroenterology"},{"key":"2021121823065401500_CIT0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/gutjnl-2018-316023","article-title":"Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease","volume":"68","author":"Zeissig","year":"2019","journal-title":"Gut"},{"key":"2021121823065401500_CIT0026","article-title":"Mucosal biomarker of innate immune activation predicts response to vedolizumab in Crohn\u2019s disease","author":"Osterman","journal-title":"Inflamm Bowel Dis"},{"key":"2021121823065401500_CIT0027","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.cgh.2019.08.030","article-title":"Expression levels of 4 genes in colon tissue might be used to predict which patients will enter endoscopic remission after vedolizumab therapy for inflammatory bowel diseases","volume":"18","author":"Verstockt","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021121823065401500_CIT0028","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2249.2009.03961.x","article-title":"Phenotypic and functional markers for 1\u03b1, 25-dihydroxyvitamin D3-modified regulatory dendritic cells","volume":"157","author":"Pedersen","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021121823065401500_CIT0029","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1182\/blood-2012-06-434779","article-title":"IL-7 induces expression and activation of integrin \u03b14\u03b27 promoting naive T-cell homing to the intestinal mucosa","volume":"120","author":"Cimbro","year":"2012","journal-title":"Blood"},{"key":"2021121823065401500_CIT0030","article-title":"Vitamin D3 supplementation improves immune and inflammatory response in vitamin D deficient adults in Taif, Saudi Arabia","volume-title":"Biomed Res","author":"Alkhedaide","year":"2016"},{"key":"2021121823065401500_CIT0031","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","article-title":"Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases","volume":"21","author":"Ananthakrishnan","year":"2017","journal-title":"Cell Host Microbe"},{"key":"2021121823065401500_CIT0032","doi-asserted-by":"crossref","first-page":"101377","DOI":"10.11131\/2018\/101377","article-title":"Regulation of microbiota by vitamin D receptor: a nuclear weapon in metabolic diseases","volume":"5","author":"Bakke","year":"2018","journal-title":"Nuclear Recept Res"},{"key":"2021121823065401500_CIT0033","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/s41598-020-64226-7","article-title":"Vitamin D receptor promotes healthy microbial metabolites and microbiome","volume":"10","author":"Chatterjee","year":"2020","journal-title":"Sci Rep"},{"key":"2021121823065401500_CIT0034","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/ijms22010362","article-title":"Vitamin D modulates intestinal microbiota in inflammatory bowel diseases","volume":"22","author":"Battistini","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2021121823065401500_CIT0035","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/ecco-jcc\/jjy052","article-title":"The effect of vitamin D on intestinal inflammation and faecal microbiota in patients with ulcerative colitis","volume":"12","author":"Garg","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2021121823065401500_CIT0036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0141076814562718","article-title":"The environment and disease: association or causation? 1965","volume":"108","author":"Hill","year":"2015","journal-title":"J R Soc Med"},{"key":"2021121823065401500_CIT0037","article-title":"Can sophisticated study designs with regression analyses of observational data provide causal inferences?","author":"VanderWeele","year":"2020","journal-title":"JAMA Psychiatry"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjab114\/40357196\/jjab114.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/15\/12\/1980\/41818779\/jjab114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/15\/12\/1980\/41818779\/jjab114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T23:09:33Z","timestamp":1639868973000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/15\/12\/1980\/6310486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,6,28]]},"published-print":{"date-parts":[[2021,12,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab114","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,6,28]]}}}